TY  - JOUR

T1  - Pazopanib versus paclitaxel in relapsed urothelial tumors: A randomized phase II study investigating pazopanib versus weekly paclitaxel in relapsed or progressive transitional cell carcinoma of the urothelium (PLUTO).

JO  - Journal of Clinical Oncology

PY  - 2014/05/20

AU  - Jones RJ

AU  - Chester JD

AU  - Dixon-Hughes J

AU  - Alexander L

AU  - Bahl A

AU  - Hussain SA

AU  - Birtle A

AU  - Jagdev S

AU  - Morris A

AU  - Stobo J

AU  - Bray CA et al

ED  - 

DO  - DOI: 10.1200/jco.2014.32.15_suppl.tps4589

VL  - 32

IS  - 15_suppl

SP  - tps4589

EP  - tps4589

Y2  - 2024/12/22

ER  -